ID

29055

Description

Ropinirole Case Report Form GSK RRL100013 GSK Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage

Mots-clés

  1. 05/10/2017 05/10/2017 -
  2. 22/02/2018 22/02/2018 -
  3. 22/02/2018 22/02/2018 -
  4. 22/02/2018 22/02/2018 -
  5. 17/09/2021 17/09/2021 -
Détendeur de droits

gsk

Téléchargé le

22 février 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Ropinirole Case Report Form GSK RRL100013

INVESTIGATIONAL PRODUCT

Investigational Product
Description

Investigational Product

Alias
UMLS CUI-1
C0304229
Planned timepoint
Description

Planned timepoint

Type de données

integer

Alias
UMLS CUI [1]
C2348792
Blinded dose level
Description

Blinded dose level

Type de données

integer

Alias
UMLS CUI [1,1]
C0178602
UMLS CUI [1,2]
C0304229
Start Date
Description

Start Date

Type de données

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C0304229
Stop Date
Description

Stop Date

Type de données

date

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C0304229
IP Container No. 1
Description

IP Container No 1

Type de données

text

Alias
UMLS CUI [1,1]
C0180098
UMLS CUI [1,2]
C0304229
IP Container No. 2
Description

IP Container No 2

Type de données

text

Alias
UMLS CUI [1,1]
C0180098
UMLS CUI [1,2]
C0304229
Has the subject missed investigational product for >2 consecutive days
Description

Has the subject missed investigational product for >2 consecutive days

Type de données

boolean

Alias
UMLS CUI [1]
C0457454
Average number of hours between early and late dose
Description

Average number of hours between early and late dose

Type de données

text

Similar models

INVESTIGATIONAL PRODUCT

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Investigational Product
C0304229 (UMLS CUI-1)
Item
Planned timepoint
integer
C2348792 (UMLS CUI [1])
Code List
Planned timepoint
CL Item
Baseline (1)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
Day 3 (2)
(Comment:en)
CL Item
Vital signs (3)
C0518766 (UMLS CUI-1)
(Comment:en)
Blinded dose level
Item
Blinded dose level
integer
C0178602 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Stop Date
Item
Stop Date
date
C0806020 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
IP Container No 1
Item
IP Container No. 1
text
C0180098 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
IP Container No 2
Item
IP Container No. 2
text
C0180098 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Has the subject missed investigational product for >2 consecutive days
Item
Has the subject missed investigational product for >2 consecutive days
boolean
C0457454 (UMLS CUI [1])
Average number of hours between early and late dose
Item
Average number of hours between early and late dose
text

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial